The Impact of Salpingectomy and Single Dose Systemic Methotrexate Treatments on Ovarian Reserve in Ectopic Pregnancy
NCT ID: NCT02714998
Last Updated: 2016-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
131 participants
INTERVENTIONAL
2013-01-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sequential Letrozole and Methotrexate Therapy Role in Treatment of Tubal Ectopic Pregnancy
NCT06426979
Methotrexate Treatment in Cases of Ectopic Pregnancy With Relative Contraindications
NCT07186127
Evaluation of Therapeutic Strategies for Treatment of Ectopic Pregnancies (EP) and Evaluation of Subsequent Fertility
NCT00137982
The Effect of Different Treatment Modalities of Tubal Ectopic Pregnancy on Ovarian Reserve: a Prospective Cohort Study
NCT06471166
The Selection of Pregnancy for Patients After Tubal Ectopic Pregnancy Treatment
NCT05498558
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Methotrexate only
Single dose of systemic Methotrexate administered to 55 patients.
Methotrexate
single dose systemic methotrexate administration (50 mg/m2)
Salpingectomy only group
Laparoscopic unilateral salpingectomy performed to 61 patients.
salpingectomy
Laparoscopic unilateral salpingectomy
Salpingectomy following Methotrexate
15 patients underwent laparoscopic unilateral salpingectomy following unsuccessful single dose of methotrexate administration.
Methotrexate
single dose systemic methotrexate administration (50 mg/m2)
salpingectomy
Laparoscopic unilateral salpingectomy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Methotrexate
single dose systemic methotrexate administration (50 mg/m2)
salpingectomy
Laparoscopic unilateral salpingectomy
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients treated with multiple doses of methotrexate or different surgical procedure (salpingostomy, milking)
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ege University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enes Taylan
Medical Doctor, Ob&Gyn Specialist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmet M. Ergenoglu, Ass. Prof.
Role: STUDY_DIRECTOR
Ege University School of Medicine Department of Obstetrics and Gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ege University School of Medicine Department of Obstetrics and Gynecology
Izmir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-TIP-043
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.